Athera signs agreements with Asbach Medical and Oxford Biosystems
Carina Schmidt, CEO of Athera, said: “We are very excited about the opportunities these agreements present to Athera. They will allow us to reach a large number of
WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.